In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.

Data are early, retrospective, and unlikely to influence guidelines, but interest among operators is growing, says Sameh ...

Diastolic BP was higher years after giving birth for women who reported stress—but only if they’d had a complicated pregnancy ...

Women had better self-care at 5 years with self-expanding valves, raising questions about lower gradients and stroke impacts.

Ami Bhatt discusses the effort to build an infrastructure and guardrails for AI and how clinicians can take part.

The study of LAAO cases provides physicians with evidence they can cite when requesting tools for additional protection.

For primary prevention patients at high risk, such as those with a 10-year risk > 10%, the LDL target is less than 70 mg/dL ...

Geography once drove disparity, but access now hinges on how effectively centers can employ modern donor-utilization tools.

Both CV mortality and major bleeding were rarer when antiplatelets weren’t added, with no tradeoff in ischemic events.

Ami Bhatt speaks to Henri Justino about strategies to support right ventricular growth, PA/IVS, and where current ...

The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most ...